Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood
Published November 12, 2026
Optimizing Reduced-Intensity Conditioning for Older Patients with AML and MDS: A Large-Scale Anal...
November 14, 2026
Medspoke
Medspoke
Blood
Published November 12, 2026
00:00
--:--
CAR-T Targeting of Mutant Calreticulin Selectively Eradicates Myeloproliferative Neoplasm-Sustain...
November 14, 2026
Share
CAR-T Targeting of Mutant Calreticulin Selectively Eradicates Myeloproliferative Neoplasm-Sustaining Stem Cells.
https://www.medspoke.co/channel_journal?id=683&tap_id=17676
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
American Journal of Hematology
Published November 13, 2026
Ravulizumab Shows Favorable Survival and Improves Clinical Markers in Children With HSCT-TMA: Res...
November 14, 2026
Why are you reporting this TALK?